Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study**Zoladex; Zeneca Pharmaceuticals, Macclesfield, United Kingdom.††Supported by Zeneca Pharmaceuticals, Macclesfield, United Kingdom.‡‡Presented at the satellite symposium of the XIV World Congress of Gynecology and Obstetrics, Montreal, Quebec, Canada, September 26 to 30, 1994.§§The following investigators and centers participated in this study: Paul Sindberg Eriksen, M.D., Central Hospital, Naestved, Denmark; Torben Phillipsen, M.D., Holbaek Central Hospital, Holbaek, Denmark; Jan Stoot, M.D., de Wever Ziekenhuis, Heerlen, The Netherlands; Juan Vanrel Diaz, M.D., Juan Carreras, M.D., Hospitalidad Clinico, Barcelona, Spain; Guillermo Lopez, M.D., Juan Alcazar, M.D.; Clinica Universitaria de Navarra, Pamplona, Spain; Tyhi Raudaskoski, M.D., Oulu University Hospital, Oulu, Finland; Lars Ronnberg, M.D., Central Hospital of Vaasa, Vaasa, Finland; Risto Tuimala, M.D., Tampere University Hospital, Tampere, Finland; Esa Korkeela, M.D., Central Hospital of Pohjois-Karjala, Joensuu, Finland; Jan Maltau, M.D., University Hospital, Tromso, Norway; Per Tore Nordmark, M.D., Lillehammer Hospital, Lillehammer, Norway; Runar Eraker, M.D., Central Hospital of Akershus, Nordbyhagen, Norway; Gudny Sando, M.D., Fjordano Central Hospital, Forde, Norway; Christine West, M.D., University of Edinburgh, Edinburgh, Scotland; Jose Falcato, M.D., Albino Aroso Ramos, M.D., Hospital Geral de Santo Antonia, Porto, Portugal; Jose Bajo Arenas M.D., Folgueira Hospital Universitario de Getafe, Madrid, Spain; Pentti Kilholma, M.D., University Central Hospital, Turku, Finland; John Price, M.D., Belfast City Hospital, Belfast, Northern Ireland; David Jenkins, M.D., Royal Victoria Hospital, Cork, Ireland; Jorge Beires, M.D., Jorge Moreira, M.D., Maria Santos, M.D., Hospital de S Joao, Porto, Portugal; Escudero Fernandez, M.D., Clinico de San Carlos, Madrid, Spain; Helge Hanken, M.D., Central Hospital, Alesund, Norway; Fatima Romao, M.D., Hospital de Garcia de Orta, Almada, Portugal; Piero Capetta, M.D., Clinica Ostetrica e Ginecologica, Milan, Italy; Alberto Morini, M.D., Policlinico Umberto, Rome, Italy.∥∥Reprint requests: Giuseppe Benagiano, M.D., University “La Sapienza,” Policlinico Umberto Rome Italy (FAX: 39-6-440-2076).

Author:

Benagiano Giuseppe,Kivinen Seppo T.,Fadini Rubens,Cronjé Hendrik,Klintorp Soren,van der Spuy Zephne M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference20 articles.

1. Use of gonadotropin-releasing hormone agonists before myomectomy;Friedman;Clin Obstet Gynecol,1993

2. Gonadotropin-releasing hormone agonists: utilization before hysterectomy;Stovall;Clin Obstet Gynecol,1993

3. Pre-surgical treatment of uterine myomas with LH-RH agonists;D’Addato;Clin Exp Obstet Gynecol,1992

4. The facts about fibroids: presentation and latest management options;Christiansen;Postgrad Med,1993

5. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas;Vercellini;Acta Obstet Gynecol Scand,1993

Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3